Vanderbilt Vaccine Center (VVC)
-
June 28, 2024
Antibody trial launched to address enterovirus threat
Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis. -
June 12, 2024
Scientists find antibodies that block parainfluenza virus infection
The antibodies may have clinical benefit as antiviral drugs to treat potentially life-threatening infections in elderly and immunosuppressed patients. -
May 31, 2024
Antibodies may aid effort to fight influenza B: study
The findings reported in the journal Immunity support the development of a monoclonal antibody for prevention and treatment of influenza B — and will help guide efforts to develop a universal influenza vaccine. -
May 8, 2024
Supercomputing redesign of a COVID monoclonal antibody
The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses. -
January 16, 2024
Following the clues through time: Old mummies, old bones and old teeth lead to new insight into disease for Katherine Van Schaik
Radiology fellow moves from present-day patients to historical artifacts to understand health and illness -
November 15, 2023
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. -
October 30, 2023
Crowe, Osheroff honored by AAMC
Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.